{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["57(3)"],"submitter":["Gong CC"],"pubmed_abstract":["Radiation‑induced lung injury (RILI) remains a dose‑limiting and life‑threatening complication of thoracic radiotherapy. The present study aimed to evaluate the therapeutic efficacy and mechanism of the naturally extracted flavonoid, 5,7,8‑trimethoxyflavone (HY‑N7656), in inhibiting RILI. Lung injury in mice was evaluated using micro‑computed tomography, histopathological analysis, enzyme‑linked immunosorbent assay and western blotting. Network pharmacology was conducted to predict the potential therapeutic targets and signaling pathways of HY‑N7656 in RILI. Cell Counting Kit‑8, wound healing, immunofluorescence, reverse transcription‑quantitative (RT‑q) PCR and protein expression analyses were carried out <i>in vitro</i> using TGF‑β‑stimulated A549 cells to evaluate epithelial‑mesenchymal"],"journal":["International journal of molecular medicine"],"pagination":["69"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC12851852"],"repository":["biostudies-literature"],"pubmed_title":["Natural compound 5,7,8‑trimethoxyflavone mitigates radiation‑induced lung injury by suppressing EMT and PI3K/Akt pathway."],"pmcid":["PMC12851852"],"pubmed_authors":["Xu K","Chen Q","Lin B","Chen MH","Mi YZ","Li HK","Chen JY","Fu SL","Quan L","Fang ZY","Lang JY","Gong CC"],"additional_accession":[]},"is_claimable":false,"name":"Natural compound 5,7,8‑trimethoxyflavone mitigates radiation‑induced lung injury by suppressing EMT and PI3K/Akt pathway.","description":"Radiation‑induced lung injury (RILI) remains a dose‑limiting and life‑threatening complication of thoracic radiotherapy. The present study aimed to evaluate the therapeutic efficacy and mechanism of the naturally extracted flavonoid, 5,7,8‑trimethoxyflavone (HY‑N7656), in inhibiting RILI. Lung injury in mice was evaluated using micro‑computed tomography, histopathological analysis, enzyme‑linked immunosorbent assay and western blotting. Network pharmacology was conducted to predict the potential therapeutic targets and signaling pathways of HY‑N7656 in RILI. Cell Counting Kit‑8, wound healing, immunofluorescence, reverse transcription‑quantitative (RT‑q) PCR and protein expression analyses were carried out <i>in vitro</i> using TGF‑β‑stimulated A549 cells to evaluate epithelial‑mesenchymal","dates":{"release":"2026-01-01T00:00:00Z","publication":"2026 Mar","modification":"2026-06-15T06:26:43.118Z","creation":"2026-06-15T03:08:30.322Z"},"accession":"S-EPMC12851852","cross_references":{"pubmed":["41574704"],"doi":["10.3892/ijmm.2026.5740"]}}